Artemether/Lemefantrine

Edina Avdic, Pharm.D.

INDICATIONS

FDA

  • Treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients with ≥ 5 kg.
    • Manufacturer does not recommend use for the treatment of severe malaria or the prevention of P. falciparum malaria.
    • Most recent CDC guidelines recommend artemether/lumefantrine use for the treatment of severe malaria following administration of IV artesunate or while waiting for IV artesunate to arrive from CDC (see CDC website)

NON-FDA APPROVED USES

  • Treatment of severe malaria due to P. falciparum following administration of IV artesunate or while awaiting for IV artesunate to arrive from CDC.
  • Treatment of uncomplicated P. vivax malaria (2015 WHO recommendations)[2].

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: June 6, 2019